학술논문
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial
Document Type
Article
Author
Kato, Shingo; Maemoto, Atsushi; Matsuura, Minoru; Sakemi, Ryosuke; Sasaki, Makoto; Tsujikawa, Tomoyuki; Esaki, Motohiro; Fukata, Norimasa; Kitamura, Kazuya; Hiraoka, Sakiko; Hokari, Ryota; Ishihara, Shunji; Mizoshita, Tsutomu; Naito, Yuji; Omata, Fumio; Saruta, Masayuki; Yoshino, Takuya; Kobayashi, Taku; Motoya, Satoshi; Nakamura, Shiro; Yamamoto, Takayuki; Nagahori, Masakazu; Tanaka, Shinji; Hisamatsu, Tadakazu; Hirai, Fumihito; Nakase, Hiroshi; Watanabe, Kenji; Matsumoto, Takayuki; Tanaka, Masanori ; Abe, Takayuki; Suzuki, Yasuo; Watanabe, Mamoru; Hibi, Toshifumi
Source
In The Lancet Gastroenterology & Hepatology June 2021 6(6):429-437
Subject
Language
ISSN
2468-1253